Status:
NOT_YET_RECRUITING
Efficacy of Topical Tranexamic Acid in Reducing Blood Loss During CS in Patients With Placenta Previa
Lead Sponsor:
Cairo University
Conditions:
Placenta Previa
Eligibility:
FEMALE
20-40 years
Phase:
NA
Brief Summary
Objectives: To evaluate the efficacy of topical tranexamic acid applied on the placental bed after placental delivery to reduce blood loss during cesarean delivery in women with placenta previa. Pati...
Eligibility Criteria
Inclusion
- Age: 20-40 years old.
- BMI less than 30 kg/m2.
- Pregnancy of singleton living fetus.
- Placenta previa by ultrasound assessment
- Gestational age \> 36 weeks.
Exclusion
- Women with a history of any medical disorder with pregnancy, e.g., Gestational diabetes and hypertension.
- Women with systemic diseases, e.g., diabetes mellites, systemic immune disorders such as systemic lupus erythematosus
- Women with bleeding tendency or coagulopathy.
- Women on anticoagulants or hemodynamically unstable women.
- Women with uterine abnormalities, such as fibroids or polyps.
- Emergency termination of pregnancy.
- Intrauterine fetal death.
- Pregnancy with obstetric hemorrhage, e.g., antepartum hemorrhage
- Cases of placenta accrete spectrum disorder or placental abruption
- Women with known allergies to Tranexamic acid
Key Trial Info
Start Date :
July 24 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT06515535
Start Date
July 24 2024
End Date
December 31 2024
Last Update
July 23 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.